Please try another search
Danaher Corporation (NYSE:DHR), a leading player in the Life Science Tools & Diagnostics sector, has recently garnered increased attention from analysts and investors alike. The company's diverse...
On Monday, Wolfe Research adjusted its stance on shares of Danaher Corporation (NYSE:DHR), upgrading the stock from Peerperform to Outperform and setting a new price target of $285.00. The research...
On Thursday, Wolfe Research made a significant adjustment to its rating for Danaher Corporation (NYSE:DHR), upgrading the stock from Peer Perform to Outperform. Accompanying this upgrade, the firm...
On Wednesday, TD Cowen maintained a positive stance on shares of Danaher Corporation (NYSE:DHR), with the firm's analyst updating the company's price target to $315 from the previous $310, while...
On Wednesday, KeyBanc Capital Markets adjusted its outlook on shares of Danaher Corporation (NYSE:DHR), increasing the price target from $290.00 to $310.00. The firm maintained its Overweight rating...
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review